Lead Author Abstract Title Type:
|
|
- Cora Nichols
- 5 years ago
- Views:
Transcription
1 AHA SS / ReSS 2017 Anaheim, CA Nov 11-15, 2017 Accepted Abstracts - 22 Total Lead Author Abstract Title Type: GWTG-National Abstracts (6) Leslie L Chang, Duke Univ, Durham, NC (AHA Young S3274 / Timing of Postdischarge Follow-Up and Medication Investigator Database Seed Grant Awardee) Adherence Among Heart Failure Patients T2103 / High Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation Irrespective of Nancy Luo, Duke Univ Medical Ctr, Durham, NC Ejection Fraction: Insights From the AHA Get With The Guidelines- Atrial Fibrillation Program S5102 / Intracranial Hemorrhage in Patients Receiving Non- Taku Inohara, Duke Clinical Res Inst, Durham, NC Vitamin K Oral Anticoagulants S3224 / Five-Year Outcomes in Patients Hospitalized With Heart Kevin S Shah, Univ of California, Los Angeles, CA Failure With Preserved, Borderline, and Reduced Ejection Fraction in the Medicare Population S3221 / Home-Time as a Novel Post-Discharge Outcome for Stephen Greene, Duke Clinical Res Inst, Durham, NC Patients Hospitalized With Heart Failure Ankur Gupta, Brigham and Women's Hosp, Boston, MA S3227 / Implementation of the Hospital Readmissions Reduction (AHA Young Investigator Database Seed Grant Program, Readmissions, and Mortality in Heart Failure Awardee) GWTG-Resuscitation Abstracts (9) Tia T Raymond, Medical City Children's Hosp, Dallas, TX R207 / Hospital Variation in Time to Epinephrine Administration for Pediatric In-hospital Cardiac Arrest R236 / Cardiac Arrest During Pediatric Cardiac Catheterization: A Javier J Lasa, Texas Children's Hosp, Houston, TX Report From the American Heart Association's Get With the Guidelines- Resuscitation Registry (GWTG-R) Lena M Chen, Univ of Michigan, Ann Arbor, MI (AHA R343 / Differences in Long-term Outcomes Among Survivors of In- Young Investigator Database Seed Grant Awardee) Hospital Cardiac Arrest Avnish Tripathi, Univ Of Louisville, Louisville, KY R179 / Circadian Variation of In-Hospital Cardiac Arrest: A Get- With-the-Guidelines Resuscitation Registry Study Mathias J Holmberg, Beth Israel Deaconess Medical 28 - Derivation and Internal Validation of a Mortality Prediction Tool for Ctr, Boston, MA Initial Survivors of Pediatric In-Hospital Cardiac Arrest Katherine M Berg, Beth Isreal Deaconess Medical Ctr, 16 - Acute Respiratory Compromise on Hospital Wards: Risks and Boston, MA Outcomes Associated With Recent Discharge From an ICU Rohan Khera, UT Southwestern Medical Ctr, Dallas, R178 / Association Between Hospital Recognition for Resuscitation TX (AHA Young Investigator Database Seed Grant Quality Measures by the American Heart Association and In-Hospital Awardee) Cardiac Arrest Survival Apurba K Chakrabarti, Univ of Michigan, Ann Arbor, MI R230 / Non-Physician Leadership of Resuscitation Teams and Survival After In-Hospital Cardiac Arrest Moderated Moderated Moderated Moderated Moderated Moderated Sarah M Perman, Univ of Colorado Sch of Med, Aurora, CO 03 - Do Race and Sex Differences Exist for Do Not Attempt Resuscitation Orders in Patients Successfully Resuscitated From In- Hospital Cardiac Arrest? ACTION Registry-GWTG Abstracts (4) Dmitriy N Feldman, Weill-Cornell Med, New York, NY John A Dodson, New York Univ Sch of Med, New York, NY Jacob A Udell, Women's Coll Hosp/Toronto General Hosp, Univ of Toronto, ON Akshay Bagai, St. Michael's Hosp, Toronto, ON, Canada Mission: Lifeline Abstracts (1) Management and Outcomes of Myocardial Infarction in the Age of Direct Oral Anticoagulants for Atrial Fibrillation: A Report From The NCDR Action Registry - GWTG S2153 / The Association of Frailty With In-Hospital Bleeding Among Older Adults With Acute Myocardial Infarction: Insights From the Action Registry-GWTG S2147 / Frailty and Mortality in Older Patients With Acute Myocardial Infarction: Observations From the NCDR ACTION Registry- GWTG M3026 / Cognitive Impairment and In-Hospital Mortality in Older Patients With Acute Myocardial Infarction: A Report From the ACTION Registry - GWTG James G Jollis, Duke Univ, Durham, NC Regional STEMI Systems of Care: Results of the Mission: Lifeline STEMI ACCELERATOR-2 Study Regional or Single Center Abstracts (2) Prepared by: B.Friesenhahn AHA SS Abstracts 2009
2 Lead Author Abstract Title Type: Shyam Prabhakaran, Northwestern Univ Feinberg Sch of Med, Chicago, IL M2138 / A Learning Collaborative Model in Chicago to Improve Door to Needle for Stroke Thrombolysis: Sustainability Made Possible Anand Ramanathan, Edward Hosp, Naperville, IL The Guideline Advantage (0) M2171 / Midwest Hospitals Resuscitation Trends in Survival Rates and Get With the Guidelines Resuscitation Award Recognition Frederick Masoudi, Aurora, CO ACC-NCDR and AHA-GWTG Registries to Meet MACRA Measures Clyde W Yancy, Chicago, IL 30 Days Hospital Readmissions and the Get With the Guidelines Heart Failure Initiative Prepared by: B.Friesenhahn AHA SS Abstracts 2009
3 Presentation Date/Time: November 12, 2017, 3:15-4:30 PM November 14, 2017, 1:30-2:45 PM November 12, 2017, 11:30-12:45 PM November 12, 2017, 11:30-12:45 PM November 12, 2017, 11:30-12:45 PM November 12, 2017, 11:30-12:45 PM Hilton Anaheim Session Location: Population Science Section, Science and Clinical III Section, Science and Session Number/Title: Session HF.APS.13 - The Hospitalized Heart Failure Patient Session EP.APS.13 - Atrial Fibrillation Session ST.APS.01 - Stroke Session HF.APS.05 - A Focus on Heart Failure Hospitalization Session HF.APS.05 - A Focus on Heart Failure Hospitalization Session HF.APS.05 - A Focus on Heart Failure Hospitalization November 12, 2017, 8:00-8:10 AM November 12, 2017, 8:40-8:50 AM (ACC North) (ACC North) Session RESS.APS ReSS Session Day 2, Section 03 Session RESS.APS ReSS Session Day 2, Section 07 November 13, 2017, 8:40-8:50 AM November 11, 2017, 1:25-1:35 PM November 13, 2017, 4:45-5:00 PM November 12, 2017, 11:30-11:45 AM (ACC North) (ACC North) Session RESS.APS ReSS Session Day 3, Section 11 Session RESS.APS ReSS Session Day 1, Section (ACC North) Session RESS.AOS.18 - Oral Abstracts 152 (ACC North) Session RESS.AOS.09B - Oral Abstracts - Clinical November 11, 2017, 1:15-1:25 PM November 12, 2017, 8:40-8:50 AM November 11, 2017, 11:00-11:15 AM (ACC North) (ACC North) (ACC North) Session RESS.APS ReSS Session Day 1, Section 14 Session RESS.APS ReSS Session Day 2, Section 06 RESS.AOS.04 - Best Oral Abstract Presentations and Presentation of the Best Abstract Awards for Cardiac and Trauma Resuscitation Science November 12, 2017, 11:40-11:45 AM Clinical Forum, Science and Technology Hall Session AC.RFO.01 - Acute Coronary Syndromes November 12, 2017, 3:15-4:30 PM November 12, 2017, 3:15-4:30 PM November 13, 2017, 12:45-2:00 PM Population Science Section, Science and Population Science Section, Science and Session QU.APS.03 - Quality Assessments in Big Data Session QU.APS.03 - Quality Assessments in Big Data Session AC.APS.10 - Acute Coronary Syndromes and Predictors of Outcomes II November 14, 2017, 5:00-5:10 PM Ballroom CD, 3rd Level (Main Building) Session LBS.06 - Evaluating Quality Improvement and Patient Centered Care Interventions Prepared by: B.Friesenhahn AHA SS Abstracts 2009
4 Presentation Date/Time: November 13, 2017, 10:30-11:45 AM November 13, 2017, 3:00-4:15 PM Session Location: Population Science Section, Science and Population Science Section, Science and Session Number/Title: Session QU.APS.06 - Outcomes Research in Coronary Heart Disease and Heart Failure Session QU.APS.09 - Cardiovascular Care and Outcomes November 13, 2017, 4:30-4:45 PM November 13, 2017, 5:45-6:00 PM 213B (Main Building) 201B (Main Building) Session QU.CVS MACRA for Dummies and MIPS for Dips: Understanding and Meeting Your Quality Measures HF.JS From Guidelines Appropriate Care to Outcomes: The Unmet Needs in Heart Failure Treatment (AHA/Argentina Cardiology Federation Joint Session) Prepared by: B.Friesenhahn AHA SS Abstracts 2009
5 AHA SS / ReSS 2017 Lead Author Abstract Title Type Sarah M Perman, Univ of Colorado Sch of Med, Aurora, CO 03 - Do Race and Sex Differences Exist for Do Not Attempt Resuscitation Orders in Patients Successfully Resuscitated From In-Hospital Cardiac Arrest? Rohan Khera, UT Southwestern Medical Ctr, Dallas, TX Avnish Tripathi, Univ Of Louisville, Louisville, KY Tia T Raymond, Medical City Children's Hosp, Dallas, TX Apurba K Chakrabarti, Univ of Michigan, Ann Arbor, MI Javier J Lasa, Texas Children's Hosp, Houston, TX Katherine M Berg, Beth Isreal Deaconess Medical Ctr, Boston, MA Stephen Greene, Duke Clinical Res Inst, Durham, NC Kevin S Shah, Univ of California, Los Angeles, CA Ankur Gupta, Brigham and Women's Hosp, Boston, MA (AHA Young Investigator Database Seed Grant Awardee) Taku Inohara, Duke Clinical Res Inst, Durham, NC Dmitriy N Feldman, Weill-Cornell Med, New York, NY Jacob A Udell, Women's Coll Hosp/Toronto General Hosp, Univ of Toronto, ON John A Dodson, New York Univ Sch of Med, New York, NY Leslie L Chang, Duke Univ, Durham, NC (AHA Young Investigator Database Seed Grant Awardee) Lena M Chen, Univ of Michigan, Ann Arbor, MI (AHA Young Investigator Database Seed Grant Awardee) Shyam Prabhakaran, Northwestern Univ Feinberg Sch of Med, Chicago, IL Akshay Bagai, St. Michael's Hosp, Toronto, ON, Canada Anand Ramanathan, Edward Hosp, Naperville, IL R178 / Association Between Hospital Recognition for Resuscitation Quality Measures by the American Heart Association and In-Hospital Cardiac Arrest Survival R179 / Circadian Variation of In-Hospital Cardiac Arrest: A Get-With-the-Guidelines Resuscitation Registry Study R207 / Hospital Variation in Time to Epinephrine Administration for Pediatric In-hospital Cardiac Arrest R230 / Non-Physician Leadership of Resuscitation Teams and Survival After In-Hospital Cardiac Arrest R236 / Cardiac Arrest During Pediatric Cardiac Catheterization: A Report From the American Heart Association's Get With the Guidelines-Resuscitation Registry (GWTG-R) 16 - Acute Respiratory Compromise on Hospital Wards: Risks and Outcomes Associated With Recent Discharge From an ICU S3221 / Home-Time as a Novel Post-Discharge Outcome for Patients Hospitalized With Heart Failure S3224 / Five-Year Outcomes in Patients Hospitalized With Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction in the Medicare Population S3227 / Implementation of the Hospital Readmissions Reduction Program, Readmissions, and Mortality in Heart Failure S5102 / Intracranial Hemorrhage in Patients Receiving Non-Vitamin K Oral Anticoagulants Management and Outcomes of Myocardial Infarction in the Age of Direct Oral Anticoagulants for Atrial Fibrillation: A Report From The NCDR Action Registry - GWTG S2147 / Frailty and Mortality in Older Patients With Acute Myocardial Infarction: Observations From the NCDR ACTION Registry-GWTG S2153 / The Association of Frailty With In-Hospital Bleeding Among Older Adults With Acute Myocardial Infarction: Insights From the Action Registry-GWTG S3274 / Timing of Postdischarge Follow-Up and Medication Adherence Among Heart Failure Patients R343 / Differences in Long-term Outcomes Among Survivors of In-Hospital Cardiac Arrest M2138 / A Learning Collaborative Model in Chicago to Improve Door to Needle for Stroke Thrombolysis: Sustainability Made Possible M3026 / Cognitive Impairment and In-Hospital Mortality in Older Patients With Acute Myocardial Infarction: A Report From the ACTION Registry - GWTG M2171 / Midwest Hospitals Resuscitation Trends in Survival Rates and Get With the Guidelines Resuscitation Award Recognition Moderated Moderated Moderated Moderated Moderated Moderated
6 Mathias J Holmberg, Beth Israel Deaconess Medical Ctr, Boston, MA Nancy Luo, Duke Univ Medical Ctr, Durham, NC James G Jollis, Duke Univ, Durham, NC 28 - Derivation and Internal Validation of a Mortality Prediction Tool for Initial Survivors of Pediatric In-Hospital Cardiac Arrest T2103 / High Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation Irrespective of Ejection Fraction: Insights From the AHA Get With The Guidelines- Atrial Fibrillation Program Regional STEMI Systems of Care: Results of the Mission: Lifeline STEMI ACCELERATOR-2 Study
7 Hilton Anaheim Date/Time Location Module November 11, 2017, 11:00-11:15 AM (ACC North) GWTG-Resus November 11, 2017, 1:15-1:25 PM (ACC North) GWTG-Resus November 11, 2017, 1:25-1:35 PM (ACC North) GWTG-Resus November 12, 2017, 8:00-8:10 AM (ACC North) GWTG-Resus November 12, 2017, 8:40-8:50 AM (ACC North) GWTG-Resus November 12, 2017, 8:40-8:50 AM (ACC North) GWTG-Resus November 12, 2017, 11:30-11:45 AM 152 (ACC North) GWTG-Resus November 12, 2017, 11:30-12:45 PM November 12, 2017, 11:30-12:45 PM November 12, 2017, 11:30-12:45 PM November 12, 2017, 11:30-12:45 PM November 12, 2017, 11:40-11:45 AM Clinical III Section, Science and Clinical Forum, Science and GWTG-HF GWTG-HF GWTG-HF GWTG-Stroke ACTION Registry- GWTG November 12, 2017, 3:15-4:30 PM November 12, 2017, 3:15-4:30 PM Population Science Section, Science and Population Science Section, Science and ACTION Registry- GWTG ACTION Registry- GWTG November 12, 2017, 3:15-4:30 PM GWTG-HF November 13, 2017, 8:40-8:50 AM (ACC North) GWTG-Resus November 13, 2017, 10:30-11:45 AM November 13, 2017, 12:45-2:00 PM November 13, 2017, 3:00-4:15 PM Population Science Section, Science and Population Science Section, Science and Single Center ACTION Registry- GWTG Single Center
8 November 13, 2017, 4:45-5:00 PM (ACC North) GWTG-Resus November 14, 2017, 1:30-2:45 PM Population Science Section, Science and GWTG-HF November 14, 2017, 5:00-5:10 PM Ballroom CD, 3rd Level (Main Building) Mission: Lifeline
9 Optional for Flyer Session RESS.AOS.04 - Best Oral Abstract Presentations and Presentation of the Best Abstract Awards for Cardiac and Trauma Resuscitation Science Session RESS.APS ReSS Session Day 1, Section 14 Session RESS.APS ReSS Session Day 1, Section 14 Session RESS.APS ReSS Session Day 2, Section 03 Session RESS.APS ReSS Session Day 2, Section 06 Session RESS.APS ReSS Session Day 2, Section 07 Session RESS.AOS.09B - Oral Abstracts - Clinical Session HF.APS.05 - A Focus on Heart Failure Hospitalization Session HF.APS.05 - A Focus on Heart Failure Hospitalization Session HF.APS.05 - A Focus on Heart Failure Hospitalization Session ST.APS.01 - Stroke Session AC.RFO.01 - Acute Coronary Syndromes Session QU.APS.03 - Quality Assessments in Big Data Session QU.APS.03 - Quality Assessments in Big Data Session HF.APS.13 - The Hospitalized Heart Failure Patient Session RESS.APS ReSS Session Day 3, Section 11 Session QU.APS.06 - Outcomes Research in Coronary Heart Disease and Heart Failure Session AC.APS.10 - Acute Coronary Syndromes and Predictors of Outcomes II Session QU.APS.09 - Cardiovascular Care and Outcomes
10 Session RESS.AOS.18 - Oral Abstracts Session EP.APS.13 - Atrial Fibrillation Session LBS.06 - Evaluating Quality Improvement and Patient Centered Care Interventions
11 Lead Author GWTG-National Abstracts (7) Abstract Title GWTG-Resuscitation Abstracts (5)
12 Type: Rec'd Sent Author Reqts Sent to AHA Reviewers Notes
13 Final rec'd for file
ACTION Registry GWTG Research and Publications Update
ACTION Registry GWTG Research and Publications Update Dr. Michael Kontos Director, Coronary Intensive Care Unit Pauley Heart Center, Virginia Commonwealth University The following relationships exist:
More informationMission: Lifeline Addressing the System of STEMI Care
Mission: Lifeline Addressing the System of STEMI Care Alice K. Jacobs, M.D. Boston University Medical Center Boston, MA, USA ACC West Virginia Chapter, April 2017 Disclosure Information FINANCIAL DISCLOSURE:
More informationAmbarish Pandey, MD UT Southwestern Medical Center Dallas,
Hospital Performance Based on 30-Day Risk Standardized Mortality and Long-Term Survival after Heart Failure Hospitalization An Analysis of the GWTG-HF Registry Ambarish Pandey, MD UT Southwestern Medical
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Chan PS, Nallamothu BK, Krumholz HM, et al. Long-term outcomes
More informationNational Cardiovascular Data Registry
National Cardiovascular Data Registry Young and Early Career Investigators ACC/AGS/NIA Multimorbidity in Older Adults with Cardiovascular Disease Workshop Ralph Brindis, MD MPH Senior Medical Officer,
More informationGet With The Guidelines: Lessons for National Healthcare Improvement Programs
Get With The Guidelines: Lessons for National Healthcare Improvement Programs Gregg C. Fonarow, MD, FACC, FAHA, FHFSA Eliot Corday Professor of Cardiovascular Medicine and Science UCLA Division of Cardiology
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of
More informationTranslating Quality Improvement into Research
Translating Quality Improvement into Research Dr. Kathryn Taubert Basel, Switzerland Cardiovascular Disease Scientist Vice President, International Science American Heart Association International Professor
More informationThe Evolving ACC-NCDR Programs: What you need to know for your practice
The Evolving ACC-NCDR Programs: What you need to know for your practice John S. Rumsfeld, MD PhD FACC Chief Science Officer and Chair, American College of Cardiology National Cardiovascular Data Registry
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total
More informationHEART FAILURE QUALITY IMPROVEMENT. American Heart Association Shawni Smith Regional Director, Quality & Systems Improvement
HEART FAILURE QUALITY IMPROVEMENT American Heart Association Shawni Smith Regional Director, Quality & Systems Improvement 1 DISCLOSURES NONE 2 3 WHY IS THIS IMPORTANT? WHY? Heart Failure Currently, an
More informationTranscatheter Aortic Valve Replacement with a Repositionable Self-expanding Bioprosthesis in Patients With Severe Aortic Stenosis Suboptimal for
Transcatheter Aortic Valve Replacement with a Repositionable Self-expanding Bioprosthesis in Patients With Severe Aortic Stenosis Suboptimal for Surgery: One-Year Results from the Evolut R US Pivotal Study
More informationST Elevated Myocardial Infarction- Latest AHA recommendations
ST Elevated Myocardial Infarction- Latest AHA recommendations Sherry Turner, DO, MPH, FACOEP Medical Director Emergency Services Wesley Medical Center The Problem 250,000 Americans each year 30% fail to
More informationClopidogrel and Aspirin in Acute Ischemic Stroke and TIA: Final Results of the POINT Trial
Clopidogrel and Aspirin in Acute Ischemic Stroke and TIA: Final Results of the POINT Trial S. Claiborne Johnston, 1 J. Donald Easton, 2 Mary Farrant, 2 William Barsan, 3 Robin A. Conwit, 4 Jordan J. Elm,
More informationResults from RE-LY and RELY-ABLE
Results from RE-LY and RELY-ABLE Assessment of the safety and efficacy of dabigatran etexilate (Pradaxa ) in longterm stroke prevention EXECUTIVE SUMMARY Dabigatran etexilate (Pradaxa ) has shown a consistent
More informationH2H Early Follow-up Challenge: See You in 7. Webinar #1 Thursday, March 3, :00 pm 4:00 pm ET. Welcome
H2H Early Follow-up Challenge: See You in 7 Webinar #1 Thursday, March 3, 2011 3:00 pm 4:00 pm ET 1 Welcome Take Home Messages Renew your H2H commitment Participate in the first H2H Challenge Help build
More informationGET WITH THE GUIDELINES- PAST AND FUTURE
GET WITH THE GUIDELINES- PAST AND FUTURE Amy Graham, RN, BS, CEN, NREMT-P Director, Quality & Systems Improvement Kentucky and Southwest Ohio American Heart Association 1 DISCLOSURE SLIDE I AM THE QUALITY
More informationTransfer in D2B. Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland. The Problem
Transfer in D2B Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland The Problem NRMI-5: North Carolina, July 2003- June 2004 NC Nation Guidelines N 2,738 79,927
More informationCONGESTIVE HEART FAILURE
CONGESTIVE HEART FAILURE ACOI IM BOARD REVIEW 2018 MARTIN C. BURKE, DO, FACOI DISCLOSURES I AM PRINCIPAL INVESTIGATOR AND RECEIVE GRANTS FOR HEART FAILURE TRIALS FROM BOSTON SCIENTIFIC, MEDTRONIC AND ST
More informationVersion 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM
Version 4.4 Institutional Outcomes Report 2014Q3 National Outcomes Report 999997 Aggregation Date: Jan 12, 2015 11:59:59 PM Publish Date: Jan 29, 2015 If User desires to publish or otherwise distribute
More informationOrganizational, or Other Financial Benefit None None None None None None. None None None None None None
Comprehensive Relationships With Industry and Other Entities AHA/ACC 2017 Update of ST-Elevation Myocardial Infarction and Non ST-Elevation Myocardial Infarction Measures Committee Jneid Hani, Chair Baylor
More informationRegional STEMI Transfer Systems: the Mayo and NC RACE Experiences
Regional STEMI Transfer Systems: the Mayo and NC RACE Experiences Dr. Henry H. Ting, Mayo Clinic College of Medicine Dr. James G. Jollis,, Duke University Medical Center Mayo Clinic STEMI System for Transferred
More informationAffordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study
Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study Tracy Y. Wang, MD, MHS, MSc, FACC, FAHA presenting on behalf of ARTEMIS Investigators Guidelines DAPT
More informationHospitalization for acute myocardial infarction (MI)
Acute and 1-Year Hospitalization Costs for Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention: Results From the TRANSLATE-ACS Registry Patricia A. Cowper, PhD; J. David Knight,
More informationST-elevation myocardial infarctions (STEMIs)
Guidelines for Treating STEMI: Case-Based Questions As many as 25% of eligible patients presenting with STEMI do not receive any form of reperfusion therapy. The ACC/AHA guidelines highlight steps to improve
More informationHF QUALITY MEASURES. Hydralazine/nitrate at discharge: Percent of black heart
Get With The Guidelines - Heart Failure is the American Heart Association s collaborative quality improvement program, demonstrated to improve adherence to evidence-based care of patients hospitalized
More informationA Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS
A Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS Magnus Ohman MB, on behalf of the GEMINI-ACS-1 Investigators
More information2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction
2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction Ramzi Khalil MD FACC Assistant Professor Allegheny Gen.Hospital AHN Speakers
More informationManagement of STEMI in era of Reperfusion. Eagles Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police
Management of STEMI in era of Reperfusion Eagles 2007 Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police STEMI in US ST Segment Elevation Myocardial Infarction (STEMI) ~500 K per year Thrombolysis
More informationClinical and Economic Value of Rivaroxaban in Coronary Artery Disease
CHRISTOPHER B. GRANGER, MD Professor of Medicine Division of Cardiology, Department of Medicine; Director, Cardiac Care Unit Duke University Medical Center, Durham, NC Clinical and Economic Value of Rivaroxaban
More informationThe PROACT Trial: valve choice has changed
The PROACT Trial: valve choice has changed Marc W. Gerdisch, MD On behalf of the PROACT Investigators; Chief Cardiovascular and Thoracic Surgery Co-director Franciscan Heart Valve Center Cardiac Surgery
More information2013, American Heart Association
2013, American Heart Association Mission: Lifeline - Data, Reports and ACTION Registry - GWTG THE MISSION: BETTER HEART ATTACK CARE FOR YOUR COMMUNITY THE LIFELINE: THE AMERICAN HEART ASSOCIATION AND YOU
More informationContinuing Medical Education Post-Test
Continuing Medical Education Post-Test Based on the information presented in this monograph, please choose one correct response for each of the following questions or statements. Record your answers on
More information2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process
Quality ID #326 (NQF 1525): Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Management of Chronic
More informationIn Process, Unpublished STS/ACC TVT Registry Manuscripts
In Process, Unpublished STS/ACC TVT Registry Manuscripts The following pages list current research and publications proposals that have been recently approved, are under analysis, are under manuscript
More informationSURGICAL ABLATION OF ATRIAL FIBRILLATION DURING MITRAL VALVE SURGERY THE CARDIOTHORACIC SURGICAL TRIALS NETWORK
SURGICAL ABLATION OF ATRIAL FIBRILLATION DURING MITRAL VALVE SURGERY THE CARDIOTHORACIC SURGICAL TRIALS NETWORK Marc Gillinov, M.D. For the CTSN Investigators ACC Late Breaking Clinical Trials March 16,
More informationTraining Program Directors' Symposium Session: Critical Care Cardiology Training
Training Program Directors' Symposium Session: Critical Care Cardiology Training David A. Morrow, MD, MPH, FACC Director, Levine Cardiac Intensive Care Unit Brigham and Women s Hospital, Boston, MA Our
More informationState Cd. PG1 Inst Name. Madigan Army Med Ctr
Specialty Inst City Inst City Specialty Anesthesiology Anesthesiology Anesthesiology Anesthesiology Anesthesiology Anesthesiology Anesthesiology/ UC San Francisco-CA Critical Care FRANCISCO CA C Walter
More informationJoo-Yong Hahn, MD/PhD
Sungkyunkwan University School of Medicine Joo-Yong Hahn, MD/PhD Heart Vascular Stork Institute, Samsung Medical Center Sungkyunkwan University School of Medicine Grant support Korean Society of Interventional
More informationCARDIOLOGY GRAND ROUNDS
CARDIOLOGY GRAND ROUNDS Presentation: Date: Location: Speaker: ACC 2015 PREVIEW Monday, March 9, 2015, 7:00 8:00 AM ANW Education Building, Watson Room Elevated Troponin in Patients Presenting to the Emergency
More informationConsensus Core Set: Cardiovascular Measures Version 1.0
Consensus Core Set: Cardiovascular s NQF 0330 Hospital 30-day, all-cause, riskstandardized readmission rate (RSRR) following heart failure hospitalization 0229 Hospital 30-day, all-cause, riskstandardized
More informationEarly Experience of Transcatheter Mitral Valve Replacement Results from the Intrepid Global Pilot Study
Early Experience of Transcatheter Mitral Valve Replacement Results from the Paul Sorajja, MD for the Investigators Presenter Disclosure Information Within the past 12 months, I or my spouse/partner have
More informationPCORnet Use Cases. Observational study: Dabigatran vs warfarin and ischemic and hemorrhagic stroke / extra-cranial bleeding
PCORnet Use Cases Observational study: Dabigatran vs warfarin and ischemic and hemorrhagic stroke / extra-cranial bleeding 1 Observational study: Dabigatran vs warfarin and stroke / bleeding Goal: Compare
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #326 (NQF 1525): Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY
More informationIn Process, Unpublished NCDR Manuscripts
In Process, Unpublished NCDR Manuscripts The following pages list current research and publications proposals that have been recently approved, are under analysis, are under manuscript development, or
More informationOverview. International Stroke Conference Update Clot buster use rises most among 80 and older stroke patients ACUTE STROKE 2/13/2015
Overview International Stroke Conference Update 2015 Nerissa U. Ko, MD, MAS University of California, San Francisco Recent Advances in Neurology February 13, 2015 Nothing to disclose Non-endovascular treatment
More informationEarly Experience of Transcatheter Mitral Valve Replacement Results from the Intrepid Global Pilot Study
Early Experience of Transcatheter Mitral Valve Replacement Results from the Paul Sorajja, MD for the Investigators Presenter Disclosure Information Within the past 12 months, I or my spouse/partner have
More informationPrimary Stroke Center Quality & Performance Measures
Primary Stroke Center Quality & Performance Measures This section of the manual contains information related to the quality performance of Primary Stroke Centers. Brain Attack Coalition Definitions Recognition
More informationSOC s Guide to the 2013 CMS New Core Measures for Stroke
SOC s Guide to the 2013 CMS New Core Measures for Stroke Since 2004, the Centers for Medicare & Medicaid Services (CMS) has collected quality data from acute care hospitals on a voluntary basis under the
More informationSubsequent management and therapies
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Subsequent management and therapies Marco Valgimigli, MD, PhD University of Ferrara ITALY
More informationBig Data Phenomics in the VA. Outline
Big Phenomics in the VA Mary Whooley MD Director, VA Measurement Science QUERI San Francisco VA Health Care System University of California, San Francisco Kelly Cho PhD MPH Phenomics Lead, Million Veteran
More informationClinical Quality Measures for PQRS. Last Updated: June 4, 2014
Clinical Quality Measures for PQRS Last Updated: June 4, 2014 The Michigan Bariatric Surgery Collaborative (MBSC) Quality Clinical Data Registry will submit the following measures outlined below on behalf
More informationAntithrombotics: Percent of patients with an ischemic stroke or TIA prescribed antithrombotic therapy at discharge. Corresponding
Get With The Guidelines -Stroke is the American Heart Association s collaborative performance improvement program, demonstrated to improve adherence to evidence-based care of patients hospitalized with
More informationACTION REGISTRY New Old ID# ID #
In Process, Unpublished NCDR Manuscripts The following pages list current research and publications proposals that have been recently approved, are under analysis, are under manuscript development, or
More informationReducing Hospital Readmissions and Increasing Time to Hospital Readmission in Blacks with Heart Failure
10th Annual National Summit on Health Disparities CBC Health Braintrust Meeting April 22 April 23, 2013, Washington, DC Reducing Hospital Readmissions and Increasing Time to Hospital Readmission in Blacks
More informationSURGICAL TREATMENT OF MODERATE ISCHEMIC MITRAL REGURGITATION: THE CARDIOTHORACIC SURGICAL TRIALS NETWORK
SURGICAL TREATMENT OF MODERATE ISCHEMIC MITRAL REGURGITATION: THE CARDIOTHORACIC SURGICAL TRIALS NETWORK Robert E. Michler, M.D. For the CTSN Investigators AHA Late Breaking Clinical Trials November 18,
More informationXi Li, Jing Li, Frederick A Masoudi, John A Spertus, Zhenqiu Lin, Harlan M Krumholz, Lixin Jiang for the China PEACE Collaborative Group
China PEACE risk estimation tool for inhospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic therapy Xi Li, Jing Li, Frederick A Masoudi, John
More informationStandards of excellence
The Accreditation Canada Stroke Distinction program was launched in March 2010 to offer a rigorous and highly specialized process above and beyond the requirements of Qmentum. The comprehensive Stroke
More informationEMS Resuscitations Centers: Bring in your Dead?
EMS Resuscitations Centers: Bring in your Dead? C. Crawford Mechem, MD EMS Medical Director Philadelphia Fire Department Department of Emergency Medicine University of Pennsylvania School of Medicine I
More informationIn Process, Unpublished NCDR Manuscripts
In Process, Unpublished NCDR Manuscripts The following pages list current research and publications proposals that have been recently approved, are under analysis, are under manuscript development, or
More information4. Which survey program does your facility use to get your program designated by the state?
STEMI SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and STEMI
More informationRisk of Subsequent Pregnancy in Women with a History of Peripartum Cardiomyopathy Uri Elkayam, MD
Risk of Subsequent Pregnancy in Women with a History of Peripartum Cardiomyopathy Uri Elkayam, MD Professor of Medicine / Cardiology Professor of Obstetrics and Gynecology University of Southern California
More informationThe OPT-UP Study. Hollie Schmidt Accelerated Cure Project for MS November 29, 2012
The OPT-UP Study Hollie Schmidt Accelerated Cure Project for MS November 29, 2012 Overview 1 study: OPT-UP 2 goals: Optimize Treatment, Understand Progression 10 lead partners: ACP and 9 clinical centers
More informationCardiothoracic Department October 9, Deborah Winters, RN BSN Clinical Excellence
Cardiothoracic Department October 9, 2013 Deborah Winters, RN BSN Clinical Excellence Quarterly Executive Summary CathPCI Registry PCI Performance Measures PCI Process/Outcome Metrics Diagnostic Cath Process/Outcome
More informationReview and presentation of current literature Dr. Nainesh Patel, Lehigh Valley Health System, PA
Why the Cath Lab for the Cardiac Arrest Patient? Dr. Michael Mooney Dr. Nainesh Patel Dr. John McPhereson Dr. Paul McMullan Dr. David Seder Review and presentation of current literature Dr. Nainesh Patel,
More informationTreatment Of Preserved Cardiac Function Heart Failure with an Aldosterone antagonist (TOPCAT) AHA Nov 18, 2014 Update on Randomized Trials
Treatment Of Preserved Cardiac Function Heart Failure with an Aldosterone antagonist (TOPCAT) AHA Nov 18, 2014 Update on Randomized Trials Marc A. Pfeffer, MD, PhD; Brian Claggett, PhD; Susan F. Assmann,
More informationControversies in ACLS Drugs: What, When, Why
Controversies in ACLS Drugs: What, When, Why Michael W. Donnino, MD Emergency Medicine and Critical Care Director of the Center for Resuscitation Science Beth Israel Deaconess Medical Center mdonnino@bidmc.harvard.edu
More informationVanderbilt Heart and Vascular Institute 2013 Comprehensive Advanced Heart Failure Summit
Vanderbilt Heart and Vascular Institute 2013 Comprehensive Advanced Heart Failure Summit Friday, August 9, 2013 7:00 AM Registration/Breakfast 7:55 AM Welcome and Opening Remarks Simon Maltais, M.D., Ph.D.,
More informationQuality Payment Program: Cardiology Specialty Measure Set
Measure Title * Reportable via PINNACLE α Reportable via Diabetes Collaborative CQMC v1.0 Measure High Priority Measure Cross Cutting Measure Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor
More informationSAPIEN 3: Evaluation of a Balloon- Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis One-Year Outcomes
SAPIEN 3: Evaluation of a Balloon- Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis One-Year Outcomes Howard C. Herrmann, MD on behalf of The PARTNER II Trial
More informationNew Study Presented at American Heart Association (AHA) Scientific Sessions 2016:
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com New Study Presented at American Heart Association (AHA) Scientific Sessions
More informationPreliminary Programme
Preliminary Programme The scientific programme comprises various styles of presentations and sessions, each offering a unique opportunity to amass new and important scientific information. Optimal management
More informationImproving Door-to-Needle Times in Acute Ischemic Stroke: Principal Results from the Target: Stroke Initiative
Improving Door-to-Needle Times in Acute Ischemic Stroke: Principal Results from the Target: Stroke Initiative Gregg C. Fonarow MD, Xin Zhao MS, Eric E. Smith MD, MPH, Jeffrey L. Saver MD, Mathew J. Reeves
More informationLeft Atrial Appendage Occlusion
Left Atrial Appendage Occlusion A new strategy to prevent stroke in atrial fibrillation Ashok Talreja MD and Arijit Chanda MD VHVI symposium 24th February 2018 Outline of presentation 1. Risk of stroke
More informationHIP ATTACK Trial: Can we improve outcomes after a hip fracture with accelerated surgery? PJ Devereaux, MD, PhD
HIP ATTACK Trial: Can we improve outcomes after a hip fracture with accelerated surgery? PJ Devereaux, MD, PhD Disclosure Member of research group with policy of not accepting honorariums or other payments
More informationNoel Eldridge, MS. AHRQ Center for Quality Improvement and Patient Safety
Presentation on: National trends in the frequency of bladder catheterization and physician-diagnosed catheterassociated urinary tract infections: Results from the Medicare Patient Safety Monitoring System
More informationTỐI ƯU HOÁ ĐIỀU TRỊ SUY TIM MẠN PGS. TS. CHÂU NGỌC HOA ĐHYD TPHCM
TỐI ƯU HOÁ ĐIỀU TRỊ SUY TIM MẠN PGS. TS. CHÂU NGỌC HOA ĐHYD TPHCM Signed by HFA / ESC/ HFSA/ ACC/ AHA Downloaded from http://circ.ahajournals.org/ at Amgen, Inc-- on May 20, 2016 3 In the year 2016, by
More informationIn Process, Unpublished STS/ACC TVT Registry Manuscripts
In Process, Unpublished STS/ACC TVT Registry Manuscripts The following pages list current research and publications proposals that have been recently approved, are under analysis, are under manuscript
More informationDoes COMPASS Change Practice?
Does COMPASS Change Practice? C. Michael Gibson, M.S., M.D. Professor of Medicine, Harvard Medical School Chief, Clinical Research, Beth Israel Deaconess CV Division Chairman, PERFUSE Study Group Founder,
More informationIs TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry
Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry E Van Belle, E Teiger, F Juthier, A Vincentelli, B Iung, H Eltchaninoff, J Fajadet,
More informationMohammad Zubaid, MB, ChB, FRCPC, FACC
Management and one year outcome of atrial fibrillation in Middle Eastern cohort enrolled in the observational Gulf Survey of Atrial Fibrillation Events (Gulf SAFE) Mohammad Zubaid, MB, ChB, FRCPC, FACC
More informationIdentification & Diagnosis of Cryptogenic Stroke What is NINDS/role
Identification & Diagnosis of Cryptogenic Stroke What is NINDS/role October 9, 2015 Scott Janis, Ph.D. Program Director, National Institute of Neurological Disorders and Stroke, The National Institute
More informationOutcomes of the Initial Experience with Commercial Transcatheter Mitral Valve Repair in the U.S.
ACC 2015 LBCT Outcomes of the Initial Experience with Commercial Transcatheter Mitral Valve Repair in the U.S. A report from the STS/ACC TVT Registry Paul Sorajja, MD, Saibal Kar, MD, Amanda Stebbins,
More informationControversies in Cardiac Pharmacology
Controversies in Cardiac Pharmacology Thomas D. Conley, MD FACC FSCAI Disclosures I have no relevant relationships with commercial interests to disclose. 1 Doc, do I really need to take all these medicines?
More informationChicago, USA June 28-30, 2018 THE SYMPOSIUM PREVENTING CARDIOEMBOLIC STROKE AS AN INTERDISCIPLINARY TEAM. hbs.kenes.com
Chicago, USA June 28-30, 2018 THE SYMPOSIUM PREVENTING CARDIOEMBOLIC STROKE AS AN INTERDISCIPLINARY TEAM hbs.kenes.com The Heart & Brain Symposium offers a comprehensive guide to primary and secondary
More informationGSK Medicine: Study Number: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationSystem Utilization 2013
System Utilization 2013 8000 7000 Contra Costa County 911 Ambulance Response and Transport By Month 2012 Through 2013 (2013 Data excludes SRVFD) Response 6000 5000 Transport 4000 3000 2000 1000 0 1/1/2012
More informationClinical and Echocardiographic Outcomes at 30 Days with the SAPIEN 3 TAVR System in Inoperable, High-Risk and Intermediate-Risk AS Patients
Clinical and Echocardiographic Outcomes at 30 Days with the SAPIEN 3 TAVR System in Inoperable, High-Risk and Intermediate-Risk AS Patients Susheel Kodali, MD on behalf of The PARTNER Trial Investigators
More informationJanuary 20, Paul Dreyer, Director Health Care Safety and Quality Massachusetts Department of Public Health 99 Chauncy Street Boston, MA 02111
January 20, 2009 Paul Dreyer, Director Health Care Safety and Quality Massachusetts Department of Public Health 99 Chauncy Street Boston, MA 02111 Dear Dr. Dreyer: We are responding to your telephone call
More informationA Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction 1
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/21543 holds various files of this Leiden University dissertation Author: Dharma, Surya Title: Perspectives in the treatment of cardiovascular disease :
More informationThe American Heart Association s Get With The Guidelines Heart
Impact of an Expanded Hospital Recognition Program for Heart Failure Quality of Care Paul A. Heidenreich, MD, MS; Xin Zhao, MS; Adrian F. Hernandez, MD, MHS; Clyde W. Yancy, MD, MSc; Lee H. Schwamm, MD;
More informationBiomarkers and Arrhythmias/Devices Ulrika Birgersdotter-Green, M.D.
Biomarkers and Arrhythmias/Devices Ulrika Birgersdotter-Green, M.D. Professor of Medicine Division of Cardiology University of California, San Diego Disclosures Honoraria, Research Grants, Medtronic Honoraria,
More informationNew tools to reduce and standardize the triage review process
New tools to reduce and standardize the triage review process JW Roden-Foreman, BA NR Rapier, MSN L Yelverton, RN ML Foreman, MD Baylor University Medical Center, Level I Trauma Center Dallas, Texas None
More informationAHA Nov 18, 2013 Late Breaking Session
Treatment Of Preserved Cardiac Function Heart Failure with an Aldosterone antagonist (TOPCAT) AHA Nov 18, 2013 Late Breaking Session Marc A. Pfeffer MD, PhD, on behalf of the TOPCAT Investigators TOPCAT
More informationAnti-thromboticthrombotic drugs
Atrial Fibrillation 2011: Anticoagulation strategies and clinical outcomes Panos E. Vardas President Elect of the ESC, Prof. of Cardiology, University Hospital of Crete Clinical outcomes affected by AF
More informationHFpEF, Mito or Realidad?
HFpEF, Mito or Realidad? Ileana L. Piña, MD, MPH Professor of Medicine and Epidemiology/Population Health Associate Chief for Academic Affairs -- Cardiology Montefiore-Einstein Medical Center Bronx, NY
More informationVariability in Antithrombotic Therapy Regimens Peri-TAVR: A Single Academic Center Experience
DOI 10.1007/s40119-015-0050-2 BRIEF REPORT Variability in Antithrombotic Therapy Regimens Peri-TAVR: A Single Academic Center Experience Jeffrey E. Rossi. Andrew Noll. Brian Bergmark. James M. McCabe.
More informationSupplementary Online Content
Supplementary Online Content Inohara T, Xian Y, Liang L, et al. Association of intracerebral hemorrhage among patients taking non vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital
More information